Treatment of knee osteoarthritic pain with platelet-rich plasma: a systematic review of clinical studies.
Rohit AiyerSelaiman NooriFrank SchirripaMichael SchirripaTalal AboudSameer JainAmitabh GulatiVinay PuttanniahSemih GungorCorey HunterPublished in: Pain management (2021)
Introduction: Knee osteoarthritis is a degenerative joint disease that is secondary to degradation of articular cartilage, reformation of subchondral bone through degradation and proliferation as well as presence of synovitis. Materials & methods: This systematic review was conducted and reported as per Preferred Reporting Items for Systematic Reviews and Meta-Analysis guidelines. Results: A total of 30 of the 48 comparators showed statistically significant superiority with platelet-rich plasma (PRP) compared with a control, while the other 16 comparators showed no significant difference between PRP and the comparator. Conclusion: We can only recommend PRP for patients with early-stage osteoarthritis (I or II) and who are aged below 65, based on our findings. Based on the Grading of Recommendations, Assessment, Development and Evaluations (GRADE) recommendations, while studies reviewed were randomized controlled studies, and therefore, high grade, due to variance in imprecision, risk of bias and inconsistency among the 37 studies, it would be reasonable to rate this paper as subjectively moderate.
Keyphrases
- platelet rich plasma
- knee osteoarthritis
- systematic review
- early stage
- high grade
- case control
- meta analyses
- clinical practice
- chronic pain
- bone mineral density
- signaling pathway
- low grade
- clinical trial
- pain management
- phase iii
- squamous cell carcinoma
- open label
- lymph node
- phase ii
- body composition
- electronic health record
- rectal cancer
- bone regeneration
- bone loss